Clinical Trial Update: Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Botensilimab plus Balstilimab versus best supportive care for chemo-refractory, unresectable colorectal adenocarcinoma; sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Colorectal Cancer | Phase 3 | Status: RECRUITING